According to a recent LinkedIn post from Attention, the company now presents its platform as HIPAA compliant and available under a signed Business Associate Agreement for customers handling protected health information. The post also notes that this comes on top of an existing security posture that has reportedly cleared SOC 2 Type II reviews with large enterprises in financial services and SaaS.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that its sales and revenue intelligence tools, including AI‑powered coaching, CRM autofill, and call intelligence, are positioned for use by teams selling into health systems, insurers, and medtech firms. The message suggests that prior security objections or stalled deals at the questionnaire stage may face fewer hurdles, potentially widening the firm’s addressable market in regulated healthcare and other compliance‑sensitive verticals.
As shared in the post, Attention emphasizes that it does not train models on customer data and that calls are encrypted in transit and at rest, with compliance documentation made available on its website. For investors, this security and compliance framing may indicate a strategic focus on winning larger, compliance‑heavy accounts, which could support higher contract values and stickier deployments if the company can convert newly accessible opportunities into signed deals.